FloSpine
We’ve Got Your Back
Overview
Raised: $162,093
Rolling Commitments ($USD)
02/04/2023
$1,318
165
2022
Healthcare & Pharmaceuticals
HealthTech
B2C
High
Low
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$1,557,981 |
$1,254,783 |
COGS |
$470,571 |
$280,235 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-699,753 |
$-166,166 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$885,057 |
$68,182 |
Accounts Receivable |
$160,731 |
$212,113 |
Total Assets |
$2,164,439 |
$1,228,098 |
Short-Term Debt |
$105,037 |
$176,552 |
Long-Term Debt |
$1,962,359 |
$229,998 |
Total Liabilities |
$2,067,396 |
$406,550 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Back pain sucks. Even worse is making a brutal decision between getting surgery or trying alternative forms of treatment. While getting rods and screws surgically inserted into your spine will alleviate pain, it is an expensive and daunting decision. Other options, like physical therapy, spinal cord stimulators, painkillers, or other types of therapy, can be ineffective.
Simply put, there is no intermediate option for patients who have tried alternative forms of therapy but do not want to have a full-blown surgery to insert rods and screws.
Until now.
FloSpine, the company I’m introducing to you today, has created a revolutionary new device called the KeyLift.